Health
J&J COVID-19 vaccine is 72% effective in the U.S., and 66% overall in large trial – Reuters
Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants which will…
(Reuters) – Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants which will give health officials another weapon to tackle the coronavirus.
FILE PHOTO: A vial and sryinge are seen in front of a displayed Johnson&Johnson logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic
In the trial of nearly 44,000 volunteers, the level of protection against moderate and severe COVID-19 varied from…
-
Noosa News22 hours agoQueensland’s building six new special schools, but there’s debate on whether they’re needed
-
Noosa News22 hours agoVolunteers help nature thrive this National Tree Day
-
General23 hours agoTrillion dollar AUKUS subs plus nuclear waste in perpetuity?
-
Noosa News18 hours agoSouth African man Jonathan Green fighting for life after horror crash on Capricorn Hwy in Queensland